Here are four points:
1. Profit Investment Management’s holdings in NuVasive were worth $1.17 million as of its most recent SEC filing.
2. NuVasive has a 12-month low of $36.81 and a 12-month high of $56.61.
3. The stock has a 50-day moving average price of $47.04 and a 200-day moving average price of $50.56.
4. The stock has a market cap of $1.96 billion.
More articles on devices:
FDA to require PMAs for 2 types of metal-on-metal hip replacement devices — 5 takeaways
ACL reconstruction gets virtual reality makeover — 5 insights
HCA, SpineGuard pen national contract — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
